The impact of COVID-19 on clinical course and treatment among patients with juvenile systemic sclerosis.

Amra Adrovic Mehmet Yildiz Fatih Haslak Sezgin Şahin Oya Koker Aybüke Gunalp Kenan BarutÖzgür Kasapçopur

Published in: Archives of rheumatology (2022)

The COVID-19 pandemic has not significantly disrupted the medical care of JSS patients. Telemedicine could be an acceptable option for JSS patients disenabled to come to the hospital.

Keyphrases

systemic sclerosis
end stage renal disease
newly diagnosed
ejection fraction
peritoneal dialysis
healthcare
prognostic factors
coronavirus disease
sars cov
interstitial lung disease
rheumatoid arthritis